Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“this threshold is much more stringent than the thresholds of IC50 ≤ 1250 nM17 or even IC50 < 5000 nM66 that were applied in earlier studies employing MAE”
From Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome (2021) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fagerberg, L., Hallström, B. M., Oksvold, P., Kampf, C., Djureinovic, D., Odeberg, J., Habuka, M., Tahmasebpoor, S., Danielsson, A., Edlund, K., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.035600 · Cited by 3,665
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Yadav, M., Jhunjhunwala, S., Phung, Q. T., Lupardus, P., Tanguay, J., Bumbaca, S., Franci, C., Cheung, T. K., Fritsche, J., Weinschenk, T., et al. (2014) · Nature · doi:10.1038/nature14001 · Cited by 1,186
Research works printed but not linked: 56
- Schumacher TN, Schreiber RD . Neoantigens in cancer immunotherapy. Science 2015; 348: 69–74. · DOI · Paper page
- Rosenberg SA, Restifo NP . Adoptive cell transfer as personalized immunotherapy for human cancer. Science 2015; 348: 62–68. · DOI · Paper page
- Sharma P, Allison JP . The future of immune checkpoint therapy. Science 2015; 348: 56–61. · DOI · Paper page
- Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N Engl J Med 2013; 368: 1509–1518. · DOI · Paper page
- Maus MV, Fraietta JA, Levine BL, Kalos M, Zhao Y, June CH . Adoptive immunotherapy for cancer or viruses. Annu Rev Immunol 2014; 32: 189–225. · DOI · Paper page
- Maus MV, Grupp SA, Porter DL, June CH . Antibody modified T cells: CARs take the front seat for hematologic malignancies. Blood 2014; 123: 2625–2635. · DOI · Paper page
- Reddy P, Maeda Y, Liu C, Krijanovski OI, Korngold R, Ferrara JL . A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nat Med 2005; 11: 1244–1249. · DOI · Paper page
- Vincent K, Roy DC, Perreault C . Next-generation leukemia immunotherapy. Blood 2011; 118: 2951–2959. · DOI
- Mutis T, Brand R, Gallardo D, van BA, Niederwieser D, Goulmy E . Graft-versus-host driven graft-versus-leukemia effect of minor histocompatibility antigen HA-1 in chronic myeloid leukemia patients. Leukemia 2010; 24: 1388–1392. · doi:10.1038/leu.2010.115
- Jenq RR, van den Brink MR . Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer. Nat Rev Cancer 2010; 10: 213–221. · DOI · Paper page
- Roopenian D, Choi EY, Brown A . The immunogenomics of minor histocompatibility antigens. Immunol Rev 2002; 190: 86–94. · DOI
- Mullally A, Ritz J . Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation. Blood 2007; 109: 1355–1362. · DOI
- Granados DP, Laumont CM, Thibault P, Perreault C . The nature of self for T cells - a systems-level perspective. Curr Opin Immunol 2015; 34: 1–8. · DOI
- Warren EH, Zhang XC, Li S, Fan W, Storer BE, Chien JW et al. Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT. Blood 2012; 120: 2796–2806. · DOI
- Blazar BR, Murphy WJ, Abedi M . Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol 2012; 12: 443–458. · DOI · Paper page
- Fontaine P, Roy-Proulx G, Knafo L, Baron C, Roy DC, Perreault C . Adoptive transfer of T lymphocytes targeted to a single immunodominant minor histocompatibility antigen eradicates leukemia cells without causing graft-versus-host disease. Nat Med 2001; 7: 789–794. · DOI · Paper page
- Meunier MC, Delisle JS, Bergeron J, Rineau V, Baron C, Perreault C . T cells targeted against a single minor histocompatibility antigen can cure solid tumors. Nat Med 2005; 11: 1222–1229. · DOI
- Li N, Matte-Martone C, Zheng H, Cui W, Venkatesan S, Tan HS et al. Memory T cells from minor histocompatibility antigen-vaccinated and virus-immune donors improves GVL and immune reconstitution. Blood 2011; 118: 5965–5976. · DOI
- Blankenstein T, Leisegang M, Uckert W, Schreiber H . Targeting cancer-specific mutations by T cell receptor gene therapy. Curr Opin Immunol 2015; 33: 112–119. · DOI · Paper page
- Schreiber RD, Old LJ, Smyth MJ . Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011; 331: 1565–1570. · DOI · Paper page
- Spierings E, Hendriks M, Absi L, Canossi A, Chhaya S, Crowley J et al. Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations. PLoS Genet 2007; 3: e103. · doi:10.1371/journal.pgen.0030103
- Bleakley M, Riddell SR . Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia. Immunol Cell Biol 2011; 89: 396–407. · DOI
- Hombrink P, Hassan C, Kester MG, Jahn L, Pont MJ, de Ru AH et al. Identification of biological relevant minor histocompatibility antigens within the B-lymphocyte-derived HLA-ligandome using a reverse immunology approach. Clin Cancer Res 2015; 21: 2177–2186. · doi:10.1158/1078-0432.ccr-14-2188
- Van Bergen CA, Rutten CE, Van Der Meijden ED, Van Luxemburg-Heijs SA, Lurvink EG, Houwing-Duistermaat JJ et al. High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning. Cancer Res 2010; 70: 9073–9083. · DOI
- Granados DP, Sriranganadane D, Daouda T, Zieger A, Laumont CM, Caron-Lizotte O et al. Impact of genomic polymorphism on the repertoire of human MHC class I-associated peptides. Nat Commun 2014; 5: 3600. · DOI
- Dolan BP, Sharma AA, Gibbs JS, Cunningham TJ, Bennink JR, Yewdell JW . MHC class I antigen processing distinguishes endogenous antigens based on their translation from cellular vs. viral mRNA. Proc Natl Acad Sci USA 2012; 109: 7025–7030. · DOI
- Yewdell JW . DRiPs solidify: progress in understanding endogenous MHC class I antigen processing. Trends Immunol 2011; 32: 548–558. · DOI · Paper page
- Nesvizhskii AI . Proteogenomics: concepts, applications and computational strategies. Nat Methods 2014; 11: 1114–1125. · DOI · Paper page
- Wolfl M, Greenberg PD . Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells. Nat Protoc 2014; 9: 950–966. · DOI
- Janelle V, Carli C, Taillefer J, Orio J, Delisle JS . Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture. J Transl Med 2015; 13: 123. · DOI
- Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA et al. A map of human genome variation from population-scale sequencing. Nature 2010; 467: 1061–1073. · DOI · Paper page
- Spierings E . Minor histocompatibility antigens: past, present, and future. Tissue Antigens 2014; 84: 374–60. · DOI · Paper page
- Majewski J, Ott J . Distribution and characterization of regulatory elements in the human genome. Genome Res 2002; 12: 1827–1836. · DOI · Paper page
- Asakura S, Hashimoto D, Takashima S, Sugiyama H, Maeda Y, Akashi K et al. Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice. J Clin Invest 2010; 120: 2370–2378. · DOI
- Flutter B, Edwards N, Fallah-Arani F, Henderson S, Chai JG, Sivakumaran S et al. Nonhematopoietic antigen blocks memory programming of alloreactive CD8+ T cells and drives their eventual exhaustion in mouse models of bone marrow transplantation. J Clin Invest 2010; 120: 3855–3868. · DOI
- Fortier MH, Caron E, Hardy MP, Voisin G, Lemieux S, Perreault C et al. The MHC class I peptide repertoire is molded by the transcriptome. J Exp Med 2008; 205: 595–610. · DOI · Paper page
- Hoof I, van Baarle D, Hildebrand WH, Kesmir C . Proteome sampling by the HLA class I antigen processing pathway. PLoS Comput Biol 2012; 8: e1002517. · DOI
- Granados DP, Yahyaoui W, Laumont CM, Daouda T, Muratore-Schroeder TL, Cote C et al. MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements. Blood 2012; 119: e181–e191. · DOI
- Caron E, Vincent K, Fortier MH, Laverdure JP, Bramoullé A, Hardy MP et al. The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation. Mol Syst Biol 2011; 7: 533. · DOI · Paper page
- Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 620–625. · DOI · Paper page
- Chappell P, Meziane EK, Harrison M, Magiera L, Hermann C, Mears L et al. Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding. Elife 2015; 4: e05345. · DOI · Paper page
- Schellens IM, Hoof I, Meiring HD, Spijkers SN, Poelen MC, van Gaans-van den Brink JA et al. Comprehensive analysis of the naturally processed peptide repertoire: differences between HLA-A and B in the immunopeptidome. PLoS One 2015; 10: e0136417. · DOI
- Caron E, Espona L, Kowalewski DJ, Schuster H, Ternette N, Alpizar A et al. An open-source computational and data resource to analyze digital maps of immunopeptidomes. Elife 2015; 4: e07661. · DOI
- Heath WR, Carbone FR . The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells. Nat Immunol 2013; 14: 978–985. · DOI · Paper page
- Bollard CM, Barrett AJ . Cytotoxic T lymphocytes for leukemia and lymphoma. Hematol Am Soc Hematol Educ Program 2014; 2014: 565–569. · DOI
- Yee C . The use of endogenous T cells for adoptive transfer. Immunol Rev 2014; 257: 250–263. · DOI
- Perreault C, Roy DC, Fortin C . Immunodominant minor histocompatibility antigens: the major ones. Immunol Today 1998; 19: 69–74. · doi:10.1016/s0167-5699(97)01185-7
- Choi EY, Christianson GJ, Yoshimura Y, Jung N, Sproule TJ, Malarkannan S et al. Real-time T-cell profiling identifies H60 as a major minor histocompatibility antigen in murine graft-versus-host disease. Blood 2002; 100: 4259–4264. · DOI
- Kim J, Ryu SJ, Oh K, Ju JM, Jeon JY, Nam G et al. Memory programming in CD8(+) T-cell differentiation is intrinsic and is not determined by CD4 help. Nat Commun 2015; 6: 7994. · DOI
- Rosinski SL, Stone B, Graves SS, Fuller DH, De Rosa SC, Spies GA et al. Development of a minor histocompatibility antigen vaccine regimen in the canine model of hematopoietic cell transplantation. Transplantation 2015; 99: 2083–2094. · DOI
- Turtle CJ, Riddell SR . Genetically retargeting CD8+ lymphocyte subsets for cancer immunotherapy. Curr Opin Immunol 2011; 23: 299–305. · DOI
- Nauerth M, Weissbrich B, Knall R, Franz T, Dossinger G, Bet J et al. TCR-ligand koff rate correlates with the protective capacity of antigen-specific CD8+ T cells for adoptive transfer. Sci Transl Med 2013; 5: 192ra87. · DOI
- Ghosh A, Holland AM, van den Brink MR . Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers. Immunol Rev 2014; 257: 226–236. · DOI
- June CH, Riddell SR, Schumacher TN . Adoptive cellular therapy: a race to the finish line. Sci Transl Med 2015; 7: 280ps7. · DOI · Paper page
- Torikai H, Reik A, Soldner F, Warren EH, Yuen C, Zhou Y et al. Toward eliminating HLA class I expression to generate universal cells from allogeneic donors. Blood 2013; 122: 1341–1349. · DOI · Paper page
- Inaguma Y, Akahori Y, Murayama Y, Shiraishi K, Tsuzuki-Iba S, Endoh A et al. Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H. Gene Ther 2014; 21: 575–584. · DOI
Cited by
Clinical potential of mass spectrometry-based proteogenomics
Zhang, B., Whiteaker, J. R., Hoofnagle, A. N., Baird, G. S., Rodland, K. D., & Paulovich, A. G. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0135-7 · Cited by 210
Sturm, T., Sautter, B., Wörner, T. P., Stevanović, S., Rammensee, H.-G., Planz, O., Heck, A. J. R., & Aebersold, R. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00386 · Cited by 63
Minor Histocompatibility Antigen-Specific T Cells
Summers, C., Sheth, V. S., & Bleakley, M. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00284 · Cited by 37
Metadata
- Authors
- Granados, D. P., Rodenbrock, A., Laverdure, J.-P., Côté, C., Caron-Lizotte, O., Carli, C., Pearson, H., Janelle, V, Durette, C., Bonneil, E., Roy, D. C., Delisle, J.-S., Lemieux, S., Thibault, P., & Perreault, C.
- ORCID
- Perreault, C
- Venue
- Leukemia
- Published
- 2016-02-09
- Volume
- 30
- Issue
- 6
- Pages
- 1344-1354
- ISSN
- 0887-6924
- 1476-5551
- Cited by
- 51
- References
- 2
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.